Matched unrelated donor HSCT for thalassemia major using treosulphan based conditioning protocol for children: A single center experience from India

• Main Authors: Khushnuma Mullanfiroze (Author), Ramya Uppuluri (Author), Divya Subburaj (Author), Dhaarani Jayaraman (Author), V.S. Venkateswaran (Author), Revathi Raj (Author), V. Lakshman (Author)
• Format: Book
• Published: Elsevier, 2017-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Hematopoietic stem cell transplantation (HSCT) is the only potentially curative treatment for patients with thalassemia major. However, only 30-35% of patients have a suitable HLA-matched family donor (MFD). We report herewith our experience with matched unrelated donor (MUD) HSCT using a treosulfan...